6D: Sex, Age, and Equity as Biological Variables in Biomaterials Research
Time: 1:30 PM to 3:30 PM
Description
This session will cover recent advances in biomaterials research and engineering innovations aimed at improving women’s health, including maternal health, reproductive technologies, gynecologic conditions, and cancers such as breast, cervical, and ovarian cancer. Speakers will present biomaterials-based approaches in drug delivery, implantable devices, diagnostics, and tissue engineering that address clinical needs unique to women. We will also emphasize sex and age as important biological variables in biomaterials research, and include emerging technologies to understand immune responses, disease mechanisms, and therapeutic outcomes. In addition,
this session will incorporate principles of health equity and biomaterials-based solutions to address health disparities.
1:30 PM. 301. Modulating acute innate immune cell infiltration to the injured brain following TBI.Amberlyn Simmons, B.S.1, Sierra Chimene, MS1, Diana Herrera-Diaz1, Crystal Willingham, M.S.1, Amanda Witten, B.S.1, Heather Bimonte-Nelson, PhD1, Chris Plaisier, PhD1, Rachael Sirianni, PhD2, Sarah Stabenfeldt, PhD1 1Arizona State University, 2UMass Chan Medical School
1:45 PM. 302. Placental cell type influence on mRNA loaded lipid nanoparticle delivery and gene expression.Alexandra Harrison1, Adelyn Fisher1, Elizaveta Tcherniaeva1, Christina Bailey-Hytholt, PhD1 1Worcester Polytechnic Institute
2:00 PM. 303. Development a Bioengineered Ovarian Implant for Physiological Hormone Restoration.Alexander Noblett1, Ferran Barrachina1, Bruna Paulsen1, Brian Pham1, Mark Johnson1, Pia Martindale1, Niloofar Motahari1, Vaishnavi Venkat1, Christian Kramme1 1Gameto
2:15 PM. 304. Dose-Dependent Effects of Extracellular Matrix Motifs Promote Bone Regeneration in Females.Victoria Garza, BS1, Opemipo Sanyaolu, BS2, Rena Bizios3, Gabriela Cervantes-Gonzales3, Teja Guda3, Alisa Isaac, PhD4 1UT San Antonio, 2University of the Incarnate Word, 3The University of Texas at San Antonio, 4St. Mary's University
2:30 PM. 305. Biodegradable Implant-Mediated Sustained Aromatase Inhibitor Delivery for Endometriosis Therapy.Lisha Awasthi1, Rohit Srivastava, Prof.1, Jayesh Bellare1 1Indian Institute of Technology Bombay
2:45 PM. 306. Sex-Specific Biomaterials Preserve Differences in Human Idiopathic Pulmonary Fibrosis Microenvironments.Haley Noelle, BS1, Mikala Mueller, BS, MS1, Rachel Blomberg, BS, PhD1, Nicole Sempertegui Plaza, BS, PhD1, Brisa Peña, BS, MS, PhD1, Chelsea Magin, BS, PhD1 1University of Colorado Denver | Anschutz
3:00 PM. 307. Minimally-Invasive Hemostatic Hydrogel with Tissue Adhesion for Postpartum Hemorrhage.Sarah Miller1, Anya Stolyarova1, Prasenjeet Ingole1, Ryan Davis Jr.1, Akhilesh Gaharwar1 1Texas A&M University
3:15 PM. 308. Bioengineered 3D Myometrium as a Functional Platform to Model Human Uterine Contractility.Karla Ortega Sandoval1, Ritu Dave2, Shreya Artha Raghavan, Associate Professor3, Antonina Frolova, Assistant Professor, Obstetrics and Gynecology Division of Maternal-Fetal Medicine2, Kaci Mitchum2, Alana Aristimuno Millan1 1Texas A&M, 2Washington University in St. Louis, 3texas a&m university